会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 2. 发明授权
    • Sulfur-containing isoquinoline derivatives in pharmaceutical
compositions and methods of use
    • 含硫异喹啉衍生物在药物组合物和使用方法中的应用
    • US4425349A
    • 1984-01-10
    • US381775
    • 1982-05-25
    • Kalman TakacsMaria H. PappGabor KovacsIlona K. AjzertAntal SimayPeter Literati NagyMarian E. PuskasGyula SebestyenIstvan StadlerZoltan Sumeghy
    • Kalman TakacsMaria H. PappGabor KovacsIlona K. AjzertAntal SimayPeter Literati NagyMarian E. PuskasGyula SebestyenIstvan StadlerZoltan Sumeghy
    • C07D217/14C07D513/04A61K31/47
    • C07D513/04C07D217/14Y10S514/826Y10S514/869
    • The invention concerns new sulfur-containing isoquinoline derivatives. More particularly, the invention relates to isoquinoline derivatives of the general formula (I) ##STR1## wherein R independently represents hydrogen, hydroxyl or alkoxy having 1 to 4 carbon atoms,R.sup.1 is hydrogen, alkyl having 1 to 4 carbon atoms and optionally substituted with phenyl, phenyl optionally substituted with one or more halogen or alkoxy group, cyano or carbamoyl,R.sup.2 is phenyl optionally substituted with one or more halogen, alkoxy or carboxyl, or a group of the general formula A ##STR2## wherein R.sup.3 is hydrogen, a straight or branched chained alkyl having 1 to 4 carbon atoms or phenyl,m and n independently represent 0, 1 or 2, with the proviso that m+n is at least 1,R.sup.4 is hydrogen, phenyl, hydroxyl, acyloxy, carboxyl, alkoxycarbonyl having 1 to 6 carbon atoms, carbamoyl, carbazoyl or dialkylamino containing 1 to 6 carbon atoms in the alkyl moiety, orR.sup.2 is a straight or branched chained alkylene group having 1 to 6 carbon atoms, andthe dotted line stands for a further carbon-carbon bond or hydrogen atoms in the 3- and 4-positions of the ring,and salts and cyclic amides thereof.The new compounds possess valuable pharmaceutical activities, more particularly, are potent diuretic, antiasthmatic, hypotensive and antiinflammatory agents. Thus another aspect of the invention is a pharmaceutical composition which comprises as active ingredient a pharmaceutically effective amount of at least one compound of the general formula (I) with at least one pharmaceutically inert carrier or diluent. The invention also relates to a process for preparing these compounds.
    • 本发明涉及新的含硫异喹啉衍生物。 更具体地说,本发明涉及通式(I)的异喹啉衍生物,其中R独立地表示氢,羟基或具有1至4个碳原子的烷氧基,R 1是氢,具有1至4个碳原子的烷基和 任选地被苯基取代,任选被一个或多个卤素或烷氧基取代的苯基,氰基或氨基甲酰基,R 2是任选被一个或多个卤素,烷氧基或羧基取代的苯基或通式A的基团,其中R 3是 氢,具有1至4个碳原子的直链或支链烷基或苯基,m和n独立地表示0,1或2,条件是m + n至少为1,R4为氢,苯基,羟基,酰氧基, 羧基,具有1至6个碳原子的烷氧基羰基,在烷基部分含有1至6个碳原子的氨基甲酰基,咔唑基或二烷基氨基,或者是具有1至6个碳原子的直链或支链的亚烷基,虚线代表 进一步c 环的3-和4-位的碳 - 碳键或氢原子,及其盐和环状酰胺。 新化合物具有有价值的药物活性,特别是有效的利尿,止喘,降压和抗炎药。 因此,本发明的另一方面是药物组合物,其包含作为活性成分的药学有效量的至少一种通式(I)的化合物与至少一种药学上惰性的载体或稀释剂。 本发明还涉及制备这些化合物的方法。